The Food and Drug Administration has granted full approval to Novavax, Inc. (NASDAQ:NVAX) COVID-19 vaccine, but with notable ...

The U.S. Food and Drug Administration approved Novavax's Covid-19 vaccine with age restrictions after a six-week delay.

After a six-week long delay, The Food and Drug Administration (FDA) has finally approved a more traditional protein-based ...

The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

Mexico halts Brazilian poultry imports after a bird flu outbreak, the U.S. FDA conditionally approves Novavax's COVID vaccine ...

Kennedy Jr., has severely restricted the use of the NovavaxCOVID-19 vaccine. The vaccine will now only be available to ...

China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...